Co-Administration of High-Dose Nebulized Colistin for <i>Acinetobacter baumannii</i> Bacteremic Ventilator-Associated Pneumonia: Impact on Outcomes

Co-Administration of High-Dose Nebulized Colistin for <i>Acinetobacter baumannii</i> Bacteremic Ventilator-Associated Pneumonia: Impact on Outcomes

<i>Acinetobacter baumannii</i> (<i>A. baumannii</i>) is a difficult-to-treat (DTR) pathogen that causes ventilator-associated pneumonia (VAP) associated with high mortality. To improve the outcome of DTR A. <i>Baumannii</i> VAP, nebulized colistin (NC) was introdu...

Full description

Bibliographic Details
Main Authors: Ioannis Andrianopoulos, Nikolaos Kazakos, Nikolaos Lagos, Theodora Maniatopoulou, Athanasios Papathanasiou, Georgios Papathanakos, Despoina Koulenti, Eleni Toli, Konstantina Gartzonika, Vasilios Koulouras
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Antibiotics
Subjects:
<i>Acinetobacter baumannii</i>
bacteremia
ventilator-associated pneumonia
nebulized colistin
mortality
critically ill
Online Access:https://www.mdpi.com/2079-6382/13/2/169

Internet

https://www.mdpi.com/2079-6382/13/2/169

Similar Items